Two additional published studies highlight WatchPAT’s accuracy and effectiveness in patients with Central Sleep Apnea (CSA) and Chronic Obstructive Pulmonary Disease (COPD) CAESAREA, Israel, Feb. 18, ...
CAESAREA, Israel, March 16, 2017 /PRNewswire/ -- Itamar Medical Ltd. (TASE: ITMR) reports that AASM, the leading medical association of sleep medicine physicians in the United States, has published an ...
A new guide from At Home Sleep Apnea Testing focuses on the potential benefits of the WatchPAT One testing device for people who may be concerned that they are suffering from sleep apnea. More ...
Caesarea, Israel-based Itamar Medical received FDA 510(k) clearance last week for a new disposable home sleep apnea test (HSAT) called WatchPAT One. The device is smartphone-connected; patients pair ...
TOKYO--(BUSINESS WIRE)--Philips Respironics GK (Headquartered in Minato Ward of Tokyo, hereafter Philips, CEO Danny Risberg) announced today that, beginning April 1, 2014, they are starting sales of a ...
CAESAREA, Israel, May 04, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical ...
CAESAREA, Israel, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the diagnosis of sleep apnea and other ...
At Home Sleep Apnea Testing announced expanded access to the WatchPAT One device for Modesto-based patients, offering a more convenient path to at-home sleep apnea testing. The wearable technology ...
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results